Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Value-based medicine in ophthalmology].

C Hirneiss1, A S Neubauer, C Tribus

  • 1Augenklinik der Ludwig-Maximilians-Universität, Mathildenstrasse 8, 80336 Munich. Christoph.Hirneiss@med.uni-muenchen.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|June 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany.

Cancer treatment and research communications·2022
Same author

[Retinal detachment in children and adolescents. Specific clinical features].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019
Same author

Comparison of Two Toric IOL Calculation Methods.

Journal of ophthalmology·2018
Same author

[Smart eye data : Development of a foundation for medical research using Smart Data applications].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016
Same author

Price Negotiation For Pharmaceuticals in Germany: High Influence Of Eu Price Weighting Method.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

[Economic Short-Term Cost Model for Stereotactic Radiotherapy of Neovascular AMD].

Klinische Monatsblatter fur Augenheilkunde·2016
Same journal

["DOG 2020 online" - for the first time in the von Graefe year].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2024
Same journal

[Are organ and co-cultures an alternative to animal models in ophthalmology?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Pediatric corneal opacities : Even small improvements provide lifelong help].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Myxoma of the conjunctiva].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Secondary open-angle glaucoma: uveitic secondary glaucoma, steroid-induced glaucoma, posttraumatic and postoperative glaucoma, tumor-related glaucoma and glaucoma due to elevated episcleral venous pressure].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
Same journal

[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2022
See all related articles

Value-based medicine (VBM) integrates treatment costs with patient-perceived value, enhancing eye care decisions. Cost-utility analysis, using quality-adjusted life years (QALYs), measures the value gained from ophthalmological interventions.

Area of Science:

  • Ophthalmology
  • Health Economics
  • Decision Science

Context:

  • Value-based medicine (VBM) is increasingly vital for strategic decisions in eye care.
  • VBM integrates treatment costs with patient-perceived value, encompassing quality and length of life.
  • Ophthalmology benefits from VBM by aligning interventions with patient outcomes and resource allocation.

Purpose:

  • To explain the methodologies of Value-based Medicine (VBM) within ophthalmology.
  • To define key terminology and introduce cost-utility analysis (CUA) in healthcare economics.
  • To highlight VBM's role in optimizing eye care decisions.

Summary:

  • Value-based medicine (VBM) enhances evidence-based medicine by incorporating cost and patient-value metrics for ophthalmological interventions.

Related Experiment Videos

  • Utility analysis, particularly the time trade-off method, quantifies patient-perceived benefits (improved quality of life).
  • Cost-utility analysis measures intervention efficiency in terms of cost per quality-adjusted life year (QALY) gained, with numerous ophthalmological CUAs published.

    • Impact:

    • Cost-utility analysis is the core of VBM, enabling cost-effectiveness estimation for ophthalmological treatments.
    • The time trade-off method facilitates comparison of ophthalmology CUAs with other medical fields.
    • VBM supports both individual patient decision-making and broader healthcare policy and resource allocation.